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Multipathwayexposures were evaluated for residents ofhouses overa 10-dayperiod following a
crack and crevice application ofachlorpyrifs-based mulaion. Three multiroom houses with
two adults each were treated. Air concentration, total deposition, and dislodgeble residue on
horizontal surfaces were measured to assess potential respiratory, oral, and dermal exposures,
respectively, in treated and untreated hg activity rooms. In addition, urine samples collected
from the adults were analyzed for theprimary metabolite ofchlorpyrifos, 3,5,6-tichloropyridi-
nol, to determine absorbeddose. The maximumchlorpyrifos air concentration observedwas 2.3
pglm3, with air concentrations generally decreasing to levels ranging from 0.1 to 0.3 pg/m3
within 10 days. Carpetdislble residues, usedtoevaluatetheamountofresiduespotentially
transferred upon contact, were less thantheanalytical methodlimitofquantitation (1.6pg/m2).
Hardplastic ballsplaedinthehomes onthe daybeforeapplication contained nodetectable dis-
lodgeable residues (<6.5 pg/m2). Ten-day cumulative non residues deposited on surfaces,
as determined by deposition pads, were less than 2.3 pg/l00 cm2. Deposition samples firom all
living areafloors collected 2 hrafter applicai ontainedlessthan 9.9 pgl00 cm2. Therefore,
contact with household surf andsubsequent hand-to-mouth activity are not expected to sig-
nificantly contribute to overall exposure. Estimated exposures to children, based on the passive
dosimetry msurements, r from 0.26 to 2.1% ofthe no observed effect level for plasma
cholinesterase depression. In addition, potential exposures to theadult residents, as indicated by
theurinary 3,5,6-TCP biomonitoring, did not increase as a result oftheapplication. Key wordk
children's toys, chlorpyrifos, disodgeable residues, nondietary exposure anddose, partide depo-
sition, pesticideapplication, pesticideresiduas, semivolatilepesticide, surfacewipes, uinarybio-
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Chlorpyrifos is used for structural, crack and
crevice, and outdoor turfand perimeter treat-
ments for the control ofpests in the urban
environment. Because ofwidespread urban
and agricultural uses, numerous toxicity and
exposure studies have been conducted over the
past 30 years to ensure that chlorpyrifos-con-
taining products are safe for both applicators
and residents ofthe treated homes. However,
fewstudies haveevaluated potential multipath-
wayexposures to adults and children following
a crack and crevice treatment-the primary
indoor use pattern for chlorpyrifos products.
Moreover, few studies have been conducted in
occupied multiroomhomes.
Previously, studies have been performed
to assess exposures to occupants following
broadcast and fogging treatments using
chlorpyrifos (1-4). When treated by these
methods, a large volume of a chlorpyrifos-
containing solution is applied to continu-
ous floor areas. In contrast, a crack and
crevice application consists of a directed
pinpoint stream to baseboards and other
cracks harboring pests. Therefore, because
residents are less prone to contact these rela-
tively inaccessible surfaces directly, potential
occupant exposure should be lower follow-
ing a crack and crevice treatment than
either a broadcast or fogger treatment.
Three studies by Wright et al. (5-7)
providelimiteddataon indoorenvironmen-
tal levels ofchlorpyrifos following crack and
crevice treatments. In 1978, Wright and
Leidy (5) measured chlorpyrifos concentra-
tions in vacant rooms following the applica-
tion of a 0.5% or 1% solution with either
an aerosol-type or compressed-air sprayer.
Air samples were collected in each of four
rooms immediately following application
and at 1-, 2-, and 3-day intervals afterappli-
cation. For all dilutions and treatments,
chlorpyrifos concentrations ranged from 0.6
to 2.7 pg/m3 immediately following appli-
cation and decreased to 0.07-0.2 pg/m3 at
3 days after application. These data demon-
strated that air concentrations immediately
following application were low relative to
the proposed NationalAcademy ofSciences
(NAS) 24-hr continuous exposure guideline
(10 pg/m3) and declined over the 3-day fol-
low-up period.
In 1975, Wright and Jackson (6) stud-
ied residual chlorpyrifos levels on nontreat-
ed surfaces for up to 8 days following a
crack and crevice treatment. In this study,
four vacant dormitory rooms were treated
with a 0.5% or 1.0% solution ofchlorpyri-
fos. Floor deposition values for chlorpyri-
fos ranged from 4 to 35 pg/m2 for the
0.5% dilution and from 4 to 113 pg/m2 for
the 1% dilution. These values represented
approximately 0.1% ofthe calculated depo-
sition levels expected from a uniform
broadcast application using a 0.5% solu-
tion. Therefore, potential dermal exposures
should be negligible following a crack and
crevice application.
This study was designed to measure
potential multipathway exposures to resi-
dents living in multiroom homes treated
with chlorpyrifos. Dosimetry techniques
consisting ofair, total surface, and dislodge-
able residues from carpet and surrogate toy
dosimeters were collected to evaluate poten-
tial exposures to children living in the home.
In addition, urinary biomonitoringwas con-
ducted for adults to directly estimate total
chlorpyrifos absorbedpostapplication.
Methods
Application oftest material. To evaluate
exposure in actual homes, three occupied
single-family homes near Indianapolis,
Indiana, were selected for this study. The
houses varied in size (90-150 m2) and style.
Except for the addition ofsampling equip-
ment, no attempt was made to change the
furnishings ofthe home.
The Dursban Pro insecticide (Dow
AgroSciences LLC, Indianapolis, IN), as a
0.5% water emulsion, was prepared accord-
ing to current EPA-accepted label instruc-
tions. The amount ofDursban Pro solution
applied to each house ranged from 663 ml to
787 ml, containing 3.32 g-3.94 g chlorpyri-
fos, respectively.
The crack and crevice treatment, with
limited spot treatments, is a typical treat-
ment for a German cockroach infestation.
A licensed applicator treated all three struc-
tures in a similar manner using a gallon-size
B & G sprayer (B & G Equipment Co.,
Plumsteadville, PA) equipped with a pres-
sure regulator and an adaptable spray-nozzle
tip, according to standard procedures for
cockroach control. In the treated rooms
(kitchen, bathrooms, and other areas poten-
tially harboring cockroaches), all materials
were removed prior to application; this
induded emptying all cabinets, drawers, and
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the pantry pursuant to standard practices. A
crack and crevice injector tip was used to
apply the test material towhere two surfaces
met inside cabinets, pantry, vanity, and
drawers (e.g., side and back, back and top,
side and bottom, etc.); to the crack between
the baseboard and wall; along the counter-
top backsplash-wall interface; under eating
table(s); and around the toilet base. The
fine fan tip was used to apply test material
in a band approximately one-third meter
wide under sinks, to the underside of
shelves and tables, under large appliances
such as a refrigerator, and to the underside
of drawers (while drawers were removed).
The pin stream tip was used only intermit-
tently to spray behind large appliances such
as a washing machine. Mechanical ventila-
tion and air flow in each house was limited
to maximize potential exposure to chlor-
pyrifos. In general, the windows remained
dosed, and the airconditioningandheating
remained off.
Human volunteers. Urine samples were
only collected from adults. Children were
specifically exduded from this study due to
logistical concerns related to the continuous
collection ofcumulative urine samples (see
Biomonitoring). The six volunteers ranged
in age from 29 to 62 years and consisted of
four women and two men. The volunteers,
two per home, were asked to follow their
normal routines during the course of this
study. The volunteers were instructed to
remain outside ofany treated room during
treatment pursuant to standard label recom-
mendations, but were not otherwise restrict-
ed. The volunteers were instructed to spend
at least 12 hr/day inside the treated home,
which was verified by a log maintained by
each volunteer.
Air monitoring. Continuous air sam-
pling for chlorpyrifos vapor and aerosol was
conducted for 10 days postapplication.
Samples were collected from the kitchen
(treated area) and another untreated adja-
cent room, such as a family room, where
residents spent alarge portion oftheir time.
At each sampling location, separate air sam-
ples were collected at approximately 0.4 m
and 1.3 m above the floor, representing the
potential breathing zones of a crawling
child and standing adult, respectively. Air
samples were drawn through a mixed cellu-
lose ester filter followed by Chromosorb
102 (SKC Inc., Eighty Four, PA) back-up
tube by a continuously operated, portable
battery-operated vacuum pump at a flow
rate of0.7-2.0 l/min. Temperatures in both
the family room and bedroom were record-
ed during each sampling interval and aver-
aged. The filters and Chromosorb tubes
were extracted with 5 ml hexane and ana-
lyzed by gas chromatography (GC) with an
electron capture detector (ECD). The
method had a limit of detection (LOD) of
0.006 pg/m3 and a limit of quantitation
(LOQ) of 0.02 pg/m3 for both filters and
Chromosorb tubes (8). Concurrent labora-
tory spiked recoveries were greater than
92%, with no observed losses during the
storage before analysis.
Deposition pads. To measure total
chlorpyrifos deposition onto nontarget
horizontal surfaces, 100-cm2 denim cloth
pads were placed on horizontal surfaces.
The denim doth pads were placed on the
floor prior to application in two rooms
where children typically spend considerable
time, such as a family room and bedroom.
The pads were collected at various time
intervals after application and analyzed for
cumulative chlorpyrifos loading. In addi-
tion, 100-cm2 denim cloth pads were
placed in both treated and nontreated
rooms and collected 2 hr following the
application. The pads were extracted with
20 ml isooctane, and the extracts were ana-
lyzed by GC/ECD. The method LOD was
0.067 pg/100 cm2 and the LOQ was 0.2
pg/100 cm2 (8). Average laboratory recov-
eries for all cloth samples, including the
two described below, were 110.0-115.2%.
Dislodgeable residues (hard-toy wipes
and carpet drags). Passive dosimetry tech-
niques were used to measure dislodgeable,
or bioavailable, chlorpyrifos residues on
horizontal surfaces. Small plastic toy balls
(8-cm diameter; Toys "R" Us, Paramus,
NJ) were employed as surrogate dosimeters
to determine the potential dislodgeability
ofresidues from domestic surfaces. In addi-
tion, aweighted drag sled was used to eval-
uate potential dermal exposures to individ-
uals when crawling upon carpeted surfaces
within the home.
Sixteen 8-cm diameter plastic toy balls
were placed on the carpet prior to applica-
tion adjacent to the deposition pads. A sin-
gle ball was randomly selected for sampling
at a predetermined interval. To ensure
complete contact with the carpeted surface,
the ball was "putted" 10 times across the
entire length of the room. The ball was
then thoroughly wiped with two 100-cm2
denim cloth squares to estimate potential
dislodgeable residues. The cloth squares
were analyzed as described above for the
deposition pads, except 40-ml isooctane
was used to extract both cloth squares
simultaneously.
Carpet drag samples were also collected
adjacent to the deposition pads for up to 10
days after treatment using theweighted drag
sled; this sled was designed to exert the
approximate pressure ofa 10-kg child stand-
ing and/or crawling across the carpeted sur-
face (9). A 100-cm2 piece of denim cloth
was affixed to the bottom of the sled and
pulled across 1.2 m ofcarpeted floor, simu-
lating a sheering motion similar to crawling.
Each "lane" (0.12 m2) was sampled only
once. Upon completion of the drag, the
denim cloth was removed and analyzed as
describedabovefor thedeposition pads.
Biomonitoring. The adult volunteers
collected all urine voided on the day before
application (day -1), the day of application
(initial exposure), and for 10 consecutive
days following the initial exposure. The
urine was analyzed for 3,5,6-trichloro-2-
pyridinol (3,5,6-TCP) (10) by acid
hydrolyzing 1.0 ml of urine spiked with
10 pl ofa 13C215N-3,5,6-TCP internal stan-
dard solution, which was then extracted
with 1.0 ml 1-chlorobutane and derivatized
with N-methyl-N-[tert-butyldimethylsilyl]
trifluoroacetamide to form the tert-butyl-
dimethylsilyl derivative. The derivative was
quantified bygas chromatographywith mass
selective detection (GC/MSD). The method
had an LOD of0.31 ng/ml and an LOQof
2 ng/ml (11). Recoveries of3,5,6-TCP from
3,5,6-TCP-spiked urine ofunexposed indi-
viduals, from 3,5,6-TCP spiked into the
volunteers preexposure urine, and from
3,5,6-TCP fortified concurrent laboratory
samples ranged from 85 to 123%. The
3,5,6-TCP in urine was stable during the
briefstorageperiodbefore analysis.
Urinary creatinine was quantified using
Sigma Diagnostics Creatinine Analysis Kit
#555-A (Sigma, St. Louis, MO) by measur-
ing the initial and final absorbance of the
samples at 500 nm. Urine collections were
considered to be complete if the average
creatinine excretion rate was within or
exceeded the literature range for creatinine
excretion (12) and/or the creatinine excre-
tion ratewas consistentwith the other urine
samples provided by that volunteer. Based
on these criteria, the amount of3,5,6-TCP
measured in the urine was adjusted for the
amount of creatinine produced in a given
24-hr period, if necessary. Based upon the
consistency between the amount of creati-
nine measured in each sample and standard
excretion rates for adults, each urine sample
was deemed to be complete.
Results
Analysis ofairsamples. The air monitoring
results are summarized in Figure 1. Air con-
centrations measured in the treated kitchen
and at the 1.3-m height were generally
higher than those measured in the adjacent
family room and at the 0.4-m height. In
house #1, the airborne chlorpyrifos levels
peaked at 0.76 pg/m3, at 0-2 hr after appli-
cation at 1.3 m above the kitchen floor.
Peak concentrations of 2.3 pg/m3 and
1.7 pg/M3 were measured at 60-72 hrand
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at 6-8 hr in houses #2 and #3, respectively,
at the 0.4-m sampling height. Low chlor-
pyrifos concentrations were measured in
house #3 before application. This was prob-
ably due to a previous chlorpyrifos dust
application noted bythe residents.
Airborne concentrations decreased to
pretreatment levels by 7 days after applica-
tion in all the homes. In houses #1 and #3,
air concentrations generally declined after
approximately 8 hr. However, peak air con-
centrations were observed on the third and
sixth days in house #2. These peak concen-
trations seemed to correlate well with the
fluctuation ofinternal temperatures.
Measured air concentrations and daily
means are summarized in Table 1. All air
concentrations were at least fourfold less
than the proposed NAS 24-hr continuous
exposure guideline of10 jig/m3. Air concen-
trations measured at the 1.3-m height were
usually slightly higher than those measured
at the 0.4-m height in all monitored rooms,
with the exception of the samples collected
in the kitchen in house #2. Compared to
measurements reported by Fenske et al. (13)
in which air concentrations above a treated
carpet were greater closer to the floor, air
concentrations following a crack and crevice
treatment did not exhibit such a pattern.
Because chlorpyrifos is not applied directly
to floors during a crack and crevice applica-
tion, it is not surprising that a concentration
gradient attributed to volatization was not
observed above the floor (see Application of
TestMaterial).
Deposition pads. The results from the
10-day cumulative deposition pads can be
found in Table 2. These results represented
the cumulative loading oftotal chlorpyrifos
residues over time on surfaces such as soft
toys or upholstered furniture in high activi-
ty rooms adjacent to treated rooms. As
with any indoor chemical use, some non-
target deposition may occur after a crack
and crevice application through volatiliza-
tion, passive transport, and redeposition
onto nontreated horizontal surfaces such as
carpets, furniture, and soft or plush toys.
Thus, a resident ofa recently treated home
may be potentially exposed to pesticide
residues through dermal contact and inci-
dental oral uptake following manual con-
tact with surfaces or objects within the
home. Residues of chlorpyrifos on deposi-
tion pads from houses #1 and #2 were
found at <0.4 pg/100 cm2. Peak residues
from house #3 were approximately 1.2
pg/100 cm2 at 6-10 days after application
(range: 1.1-1.3 pg/100 cm2). Both back-
ground and deposition pad residue levels
from house #3 were comparatively higher
than in the other homes. This may be due
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Figure 1. Air concentrations of chlorpyrifos in houses #1 (A), #2 (B), and #3 (C) resulting from residential
crack and crevice and spotapplications of Dursban Pro.
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Table 1. Daily time weighted air monitoring results from houses #1, #2, and #3 treated with chlorpyrifos
crack and crevice and spotapplications
Family room Family room Kitchen Kitchen
(0.4m) (1.3 m) (0.4m) (1.3m) Mean
House #1
Preapplication BLOQ BLOQ BLOQ BLOQ <0.02
Day 1 0.159 0.194 0.429 0.423 0.301
Day2 0.100 0.156 0.280 0.346 0.221
Day3 0.094 0.127 0.240 0.241 0.176
Day4 0.100 0.085 a 0.132 0.106
Day 5 0.075 0.107 a 0.177 0.120
Day6 0.050 0.088 0.185 0.188 0.128
Day7 0.065 0.103 0.170 0.166 0.126
Day8 0.056 0.067 0.124 0.136 0.096
Day9 0.061 0.108 0.147 0.151 0.117
Day 10 0.087 0.101 0.124 0.137 0.112
House #2
Preapplication ND ND ND ND <0.006
Day 1 0.263 0.347 0.530 0.661 0.450
Day2 0.366 0.368 0.638 0.617 0.497
Day3 0.414 0.408 1.344 0.777 0.736
Day4 0.258 0.290 0.760 0.633 0.485
Day5 0.411 0.492 1.025 0.810 0.685
Day6 0.545 0.567 1.560 0.938 0.903
Day7 0.617 0.389 0.783 0.708 0.624
Day8 0.326 0.306 0.445 0.472 0.387
Day9 0.294 0.183 0.303 0.297 0.269
Day 10 a 0.187 0.356 0.332 0.292
House#3
Preapplication 0.442 0.296 0.377 0.339 0.364
Day 1 0.383 0.466 1.218 1.023 0.773
Day2 0.319 0.437 0.861 1.057 0.669
Day3 0.264 0.377 0.708 0.746 0.524
Day4 0.301 0.432 0.928 0.792 0.613
Day5 0.170 0.474 0.819 0.726 0.547
Day6 0.271 0.382 0.667 0.672 0.498
Day7 0.191 0.269 0.371 0.425 0.314
Day8 0.165 0.176 0.373 0.334 0.262
Day9 0.156 0.242 0.415 0.358 0.293
Day 10 0.196 0.308 0.367 0.448 0.330
Abbreviations: BLOQ, below limit of quantitation (LOQ = 0.02 pg/m3); ND, not detected (limit of detection = 0.006 pg/m3).
Values shown are inpg/mr3.
aNo data reported dueto sampling pumpfailure.
Table3. Deposition on floors in treated and untreated living areas after 2 hr
Location House #1 House #2 House #3
Kitchen, floor center (on box, house #3) 9.881' BLOQ
Living roomfloor, center ND ND
Living roomfloor, east (west, house#2) ND ND
Living room floor, south end (near kitchen) - 0.213
Living roomfloor, north end - -b0.203
Hallway east ND BLOQ
Hallwaywest ND ND BLOQ
South entrywayfloor BLOQ ND
Eastentry,floor 0.315
Basement recreation room, floor ND
Basement recreation room, south floor ND
South bedroom, floor ND ND
Northwestbedroom,floor ND ND 0.251
Southwestbedroom,floor center ND
Northeast bedroom, floor ND
Dining room floor - 0.256
Abbreviations: -, data not collected (a 100-cm2 deposition pad could not be or was not placed in thatlocation); ND, not
detectable [results were less than the limit of detection (LOD = 0.067 pg/100 cm2)]; BLOQ, below limit of quantitation (LOQ
= 0.20 pg/100 cm2). Values shown are in pg/100 cm2.
'Deposidon pad placed directly undertreated table.
bDeposition pad appeared to have been stepped on.
Table 2. Summary of cumulative chlorpyrifos
loading on deposition pads from houses treated
with chlorpyrifos crack and crevice and spot
applications
Time House #1 House #2 House #3
-1 day ND/ND ND/ND 1.435/BLOQ
1 hr ND/ND ND/ND 0.397/0.225
2 hr ND/ND ND/ND 0.399/0.205
4hr ND/ND ND/ND 0.378/0.211
8 hr BLOQ/ND BLOO/ND BLOO/0.225
12 hr BLOO/BLOQ ND/ND 0.623/0.233
1 day BLOO/BLOQ ND/ND 2.298/0.271
2 days BLOO/BLOQ BLOO/ND 0.545/0.353
3 days BLOO/0.228 BLO0/BLOQ 0.665/0.352
4days 0.245/0.236 BLO0/BLOQ 0.678/0.416
5days 0.200/0.249 0.243/BLOQ 0.995/0.452
6 days 0.255/0.232 0.303/BLOQ 1.252/0.568
7 days 0.315/0.274 0.352/0.216 1.073/0.535
8 days 0.281/0.310 0.416/0.223 1.283/0.566
9 days 0.319/0.293 0.395/0.327 1.158/0.620
10 days 0.351/0.288 0.432/0.342 1.148/0.586
ND, not detected [results were less than limit of detec-
tion (LOD = 0.07 pg/100 cm2)]; BLOQ, below limit of quanti-
tation (LOQ = 0.2 pg/100 cm2). Values shown are for fami-
ly room/bedroom and are in pg/100 cm2.
reported by the residents. Based on cumu-
lative residues found on the deposition
pads, the rate of nontarget deposition
decreased over time, with negligible addi-
tional deposition and accumulation after
approximately 7 days.
In addition to the 10-day cumulative
deposition pads collected from two loca-
tions in the house, deposition pads were
collected from all living area floors
throughout the house at 2 hr after applica-
tion to determine nontarget drift immedi-
ately after application. A summary ofthe 2-
hr deposition pads can be found in Table
3. These results were generally in the range
of the preexposure samples (Table 2),
except for a single sample (9.9 pg/100
cm2), which was located directly beneath
the treated kitchen table. Because of its
proximity to a treated surface and the fact
that it contained much more chlorpyrifos
than the other 2-hr deposition samples,
this sample was considered an outlier.
Dislodgeable residues (carpet drag and
hard-toy wipes). Bioavailable, or dislodge-
able, residues were negligible, as measured
with the sled and the toy balls. In the bed-
room of all three houses and the family
rooms ofhouses #1 and #2, there were no
detectable chlorpyrifos residues (LOD =
0.00005 pg/cm2) on carpet drag samples.
Only the carpet drags from the family room
of house #3 contained sufficient dislodge-
able residues to detect, although all were
below the method LOQ(0.00016 pg/cm2).
Moreover, no detectable dislodgeable
residues were measured (<LOD = 0.00065
pg/cm2) on the hard-toy dosimeters, with
the exception ofa single sample (one of48
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Table 4. Summary of urinary 3,5,6-trichloro-2-pyridinol (3,5,6-TCP) levels (calculated chlorpyrifos amounts)
fromvolunteers exposed to crackand crevice and spotapplications ofDursban Pro
Volunteer 11-Day cumulative Average daily excretion
(house, Preexposure minus background (Absorbed chlorpyrifos)
person) (pg/kg bw/day) (pg/kg bw)8 (pg/kg bw/day)
#1A 0.13(0.31)b 0.40 (0.00-0.16/day) 0.037c (0.090)d
#1B 0.07(0.18) 0.34(0.00-0.07/day) 0.031 (0.077)
#2A 0.04(0.11) 0.39(0.00-0.07/day) 0.036(0.090)
#2B 0.09(0.21) 0.01 (0.00-0.01/day) 0.001 (0.002)
#3A 0.31 (0.77) 0.11 (0.00-0.06/day) 0.010(0.023)
#3B 0.35(0.87) 0.03(0.000.03/day) 0.003(0.009)
11a -Day cumulative 3,5,6-TCP =
En =Oton=10(Urinary3,5,6-TCP ConcentrationoDayn - (Urinary Preapplication 3,5,6-TCP)day 1.
bAbsorbed chlorpyrifos was calculated using the3,5,6-TCPfound on day-1 andthefollowing formula:
( 350.6
Background 3,5,6-TCP 0.7151 198
exposure = Excreted on day -1+ (fraction oforal dose x (molecularweight
(g/kg bw/day)) (pugIkg bw) eliminated in urine) ratio of
chlorpyrifos toTCP()
cCalculated by dividing the 11-day cumulative 3,5,6-TCP(pg/kgbw/day( by 11.
dCalculated using the equation for preexposure chlorpyrifos and average daily3,5,6-TCP excretion levels.
Table5. Estimated absorbed dosesfor children for each monitored house
Estimated Estimated Estimated Total estimated Margin of
respiratory dermal dose oral dose absorbed dose exposure
Child dose (pg/kg). (pg/kg) (pg/kg)b (pg/kg) (% of NOEL)c
House #1 0.19 NDd 0.07 0.26 385(0.26)
House#2 0.62 ND 1.48 2.10 48(2.10)
House #3 0.46 ND 0.34 0.80 125(0.80)
Abbreviations: NOEL, no observed effectlevel; ND, notdetected.
°Assumed that 100% of inhaled chlorpyrifos was absorbed via pulmonary absorption; usedthe highest air concentration for calculation.
bUsed highestsingle residue resultfrom deposition pads(Table2( and assumed 100% ofthe residue was removed when mouthed.
cHuman NOEL of 100 pg/kg bw/day corresponds to plasma cholinesterase inhibition. Margin of Exposure = (acute NOEL)/(Total Estimated
Absorbed Dose).
dContributing residue values were zero, resulting in nondetectable dermal exposures.
hard-toy samples collected) from house #3
that contained 0.00199 pg/cm2 chlorpyri-
fos at 8 hr after application in the family
room, slightly above the analytical method
LOQof0.00194 pg/cm2 and probably the
artifact of a chlorpyrifos-containing dust
applied before the start of this study.
Similarly, Lu and Fenske (14) recently
reported that only 0.78% of chlorpyrifos
applied directly to carpet was dislodgeable 1
hrafter abroadcast application.
Previous studies have evaluated several
dislodgeable residue techniques, including
hand presses, weighted sleds, and surface
rollers, for estimating the fraction ofa sur-
face residue that is dislodgeable (15). Hand
press technique, (i.e., pressing bare hands
on a treated surface and then washing the
hands with solvent) generally dislodge less
residue than sled and roller techniques due
to the sheering motion of the sled (16).
Therefore, the use of a sled technique
should result in a conservative estimate of
actual dislodgeable residues upon human
contact with a surface (15).
Biomonitoring results. Chlorpyrifos
doses actually absorbed by adult residents
were assessed with biological monitoring
techniques. By quantifying the amount of
chlorpyrifos metabolite excreted in the urine,
the amount ofchlorpyrifos absorbed via all
routes can be calculated (10). In addition,
biomonitoring ofadults can be used to vali-
datetheroute-specific exposure dataas deter-
mined with the dosimetry techniques by
comparing actual absorbed doses with expo-
sures calculated from environmental mea-
surements.
The volunteers were instructed to avoid
exposure to chlorpyrifos during the week
before application. Because the half-life for
excretion of3,5,6-TCP is approximately 24
hr (10), thevolunteers would have reached a
steady state of3,5,6-TCP elimination on the
day before application (day -1). Thus, the
3,5,6-TCP in their preexposure urine would
represent their background exposure, as
reported inTable4. Forall ofthevolunteers,
the preapplication exposure urinary 3,5,6-
TCP levels were consistent with reference
concentration levels for the general popula-
tion, at the 99th percentile, as reported by
Hill et al. (1;7). Byconverting the3,5,6-TCP
excretion values into equivalent chlorpyrifos
concentrations, the calculated preexposure
chlorpyrifos exposure values ranged from
0.11 to 0.87 pg/kgbodyweight (bw)/day for
allstudyparticipants (Table4).
The amount of 3,5,6-TCP in the urine
was quantified for each of the 11 days of
urine collection following application. Daily
excreted 3,5,6-TCP levels for individualvol-
unteers were low in comparison to their
baseline exposures (Table 4). For all volun-
teers, the 11-day cumulative urinary 3,5,6-
TCP amount excreted during the sampling
period, with the individuals' background
level subtracted, was calculated (Table 4).
The excretion rate for 3,5,6-TCP over time
is well understood (10). However, because
the volunteers were potentially reexposed to
chlorpyrifos each time they reentered their
home, use ofan excretion rate from a one-
time exposure was not appropriate.
Therefore, the daily average amount of
3,5,6-TCP excreted during the entire sam-
pling period was calculated (Table 4). The
daily average 3,5,6-TCP amount was subse-
quently used to calculate the daily average
amount ofchlorpyrifos absorbed.
Discussion
Potential absorbed chlorpyrifos doses may
be estimated for residents within the treat-
ed homes. Total multipathway exposures
may consist ofrespiratory, dermal, and oral
exposures. Although biological monitoring
was performed exclusively for the adults,
exposures to children may be estimated
using the residue measurements collected
with passive dosimetry.
Child's respiratory exposure. Potential
exposures may be estimated for residents
within the treated homes. Respiratory
exposures to children were estimated using
the following exposure equation:
Child's Respiratory Dose(pg/kg bw/day) =
Cx D x BPbw (1),
where C = highest measured air concentra-
tion at the 0.4-m height (pg/m31day); D =
estimated time spent within treated home
[0.831 days (child) (18)]; BR= individual res-
piratory rate [6.5 m3/day (child) (19)]; and
bw =bodyweight [childbw = 20kg(4)].
Maximum air concentrations measured
in each structure were used to calculate
conservative potential daily respiratory
doses for children living in each home. As a
result, estimated inhalation doses were
0.19, 0.62, and 0.46 pg/kg bw/day based
on air concentrations of 0.7 pg/m3, 2.3
pg/m3, and 1.7 pg/m3 (Figure 1 A-C) for
houses #1, #2, and #3, respectively (Table
5). All daily 24-hr time-weighted average
(TWA) air concentrations measured at 0.4
m were less than 1.6 pg/m3 (Table 1),
which is at least fivefold lower than the
NAS guideline of 10 pg/m3 (20). In addi-
tion, the highest 12-hr TWA air concentra-
tion was 2.3 pg/m3 (Fig. 1B, 60-72 hr).
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Therefore, even the highest instantaneous
exposure is approximately four times less
than the NAS guideline.
Child's nondietary oral and dermal
doses. Potential nondietary oral doses from
licking asoft toylocated in a treated or high
activity room can be estimated by using the
following general exposure equation:
Nondietary oral dose =
TRx DRT x SAT/bw (2),
where TR = total residue on the deposition
pad surface (pg/100 cm2/day), representa-
tive' oifa soft toy (Tables 2, 3); DRT = dis-
lodgeable residue from toy due to chewing
(= 100%); SAT = surface area of soft toy
[300 cm2 (4)]; and bw = body weight
[child bw = 20 kg (4)].
Estimated nondietary oral doses were
0.07, 1.48, and 0.34 pg/kg bw/day based on
maximum residues of 0.44, 9.9, and 2.3
pg/100 cm2 measured on deposition pads in
houses #1, #2, and #3, respectively (Table
5). As mentioned earlier (see deposition
pads results), although the dosimetrysample
containing 9.9 pg/100 cm2 seemed to be an
outlier from this data set given the negligible
residues found on all the other pads, this
samplewas still was induded in this analysis.
Achild's exposure is largelyafunction ofthe
amount of residue present on a toy surface
and the amount ofresidue that may be dis-
lodged upon licking or mouthing it. The
quantityofchlorpyrifos removed from a sur-
face by an aqueous (polar) solvent such as
saliva was not estimated in this work.
Instead, the calculations used the conserva-
tive assumption that all of the chlorpyrifos
residue found on the deposition pad could
be removed by a child's saliva. As a result,
mouthing frequency was not important to
this evaluation. The oral-exposure calcula-
tion provided a conservative estimate of
nondietary exposure because the assumption
was made that the child chewed on the soft
toy containing the highest cumulative
residues on a deposition pad and that all of
the surface residue was subsequently ingest-
ed (Tables 2, 3).
Accumulation ofsemivolatile pesticides
on surfaces within the home following
broadcast application have recently been
reported by Gurunathan et al. (4). In that
study, cumulative residues on foam-contain-
ing felt toys (10,000-80,000 pg/100 cm2)
located in treated apartment rooms were at
least four orders ofmagnitude greater than
the amount measured on the deposition
pads following crackand crevice application.
The residue differences maybe explained by
the differences in the type ofapplication, the
volume of pesticide applied, and the the
nature of the dosimeters used. In addition,
Gurunathan et al. (4) did not evaluate the
amount ofresidue transferred from the toy.
Extraction of a matrix with a nonpolar
organic solvent, as conducted by
Gurunathan et al. (4), probably would
remove more chlorpyrifos residue than
expected following either casual human con-
tactwith the surface ofatoyorplacement of
an object in one's mouth, as evidenced by
dislodgeable residue results. The need to use
anonpolarsolventversus an aqueous solvent
to efficiently desorb residues from denim
dosimeters likely supports this assumption
(21).
Potential dermal exposure to children
can be assessed by using the following gen-
eral exposure equation:
Dermal exposures from contact with
household surfaces in high activity rooms =
DRcx SAcx DA/bw (3),
where DRh = dislodgeable residue from car-
pet (pg/m 2), SAC = surface area contacted
by crawling child [0.1-2.2 m2/day (13)],
DA = dermal absorption [1% (10)], and bw
= bodyweight [child bw = 20 kg (4)].
Because only a single carpet dislodgeable
residue and hard-toywipe sample contained
any detectable residues (the single sample
contained only 0.006 pg/m2 above the
LOQand may be due to an earlier applica-
tion), the likelihood ofchlorpyrifos residues
being transferred from a surface to a child is
remote. Moreover, if minimal nontarget
residues deposited onto household surfaces
are contacted by the resident, less than 3%
ofthe chlorpyrifos will be absorbed through
the skin (10). Houghton et al. (16) reported
actual transfer coefficients from chlorpyri-
fos-containing upholstery to human hands
of approximately 0.05-0.71% following an
indoor application. If the deposited chlor-
pyrifos is physically adsorbed onto or into
the matrix, chlorpyrifos residues may not be
available upon contact. Therefore, because
this route would contribute little to a child's
overall potential exposure, dermal exposures
wereexcluded from this exposure assessment
(Table 5).
Risk assessmentfor children. The total
estimated absorbed dose for a child from all
potential routes following a crack and
crevice application are summarized in Table
5. Since air measurements indicated that
chlorpyrifos dissipates from the structure in
3-7 days and no further accumulation of
surface deposition occurs within the same
time period, comparison ofexposures to an
acute or short-term end point is appropriate
forevaluating hazard (22). Thus, the toxico-
logical end point used by the EPA following
short-term oral exposure to chlorpyrifos, the
NOELassociatedwithplasmacholinesterase
inhibition (100 pg/kg bw/day) was used for
this study. The resulting margin ofexposure
[MOE; the ratio of the NOEL (100 pg/kg
bw/day) to the absorbed dose] would be
greater than 150. For this assessment, the
conservative assumption was made that a
child may be exposed to maximum air con-
centrations for 0.83 days (20 hr), although
the highest concentrations lasted for only 12
hr or less Since exposures associated with a
crack and crevice (or spot) application are
transient and decrease over a 7-day period
after application and any actual absorbed
dose of chlorpyrifos is rapidly metabolized
and excreted (10), it is unlikely that there
would be any cumulative effects from subse-
quentcrackand crevice treatments separated
by the minimum 7-day application interval
on the product label.
Exposure assessment for adults.
Biomonitoring results indicated that the
daily average urinary 3,5,6-TCP excretion
amounts, with background subtracted,
were low and consistent with baseline mea-
surements (Table 4). Although the urine of
the volunteers #1B, #2A, and #3B showed
an increase of3,5,6-TCP on 0, 1, and/or 2
days consistent with the higher air concen-
trations, the biomonitored level on slubse-
quent days was not consistent with expect-
ed patterns for chlorpyrifos exposure and
subsequent 3,5,6-TCP excretion, based on
reported pharmacokinetics (10). There was
a slight increase of average 3,5,6-TCP
excreted for each volunteer per day
(0.001-0.037 pg/kg bw/day) (Table 4) fol-
lowing the application. This increase corre-
sponds to 0.002-0.09 pg/kg bw/day of
chlorpyrifos absorbed by each adult volun-
teer on average per day following the appli-
cation. Therefore, the exposure from the
crack and crevice treatment is approximate-
ly equal to or significantly less than back-
ground levels associated with typical
dietary exposures from agricultural com-
modities. Chlorpyrifos equivalent levels,
extrapolated from the 3,5,6-TCP measure-
ments, are well below the NOEL of 100
pg/kg bw/day and result in an MOE of
greater than 1,000.
Similarly, potential adult absorbed doses
were calculated using the dosimetry data.
Because potential dermal exposures to adults
are expected to be negligible based upon the
dislodgeable residue results, the air monitor-
ing data may be sufficient to estimate total
exposure to an adult. Respiratory exposures
were calculated using the equations previous-
lydescribed for children, adjusting thevalues
ofthe constants D, BR and bw. Estimated
inhalation exposures to adult women were
calculated to be 0.096, 0.144, and 0.193
pg/kg bw/day, based on maximum air
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concentrations at the 1.3-m height of 0.8
pgIm3Iday, 1.1 pg/m3Iday, and 1.5
pgIm3Iday (Fig. 1 A-C) for houses #1, #2,
and #3, respectively (where D = 0.67 days
(23), BR = 11.3 m3/day (23), and bw =
60 kg). Based on this evaluation, the result-
ing MOE is at least 500. Consequently, the
absorbed doses, as precisely determined with
biomonitoring, are considerably lower than
estimates derived from the air monitoring
measurements.
Conclusions
Air monitoring and dosimetry data were
used to estimate chlorpyrifos exposure to
adults and children following a crack and
crevice application. By employing a moni-
toring scheme that evaluated potential sur-
face and air residues in both treated rooms
and adjacent untreated rooms ofhigh activi-
ty, potential multipathway exposures were
evaluated. Inhalation exposure was deter-
mined to be the dominant exposure path-
way for the adult residents. For adults, the
calculated MOEwas approximately 500 and
greater than 1,000, based upon the dosime-
tryand biomonitoring results, respectively.
In addition, children's estimated
absorbed doses were calculated from the air
monitoring and dosimetry data. The
dosimetry data suggested low respiratory,
oral, and dermal exposures for children
playing in treated or adjacent rooms, even
when conservative assumptions were used.
The results presented in this paper suggest
that redeposited chlorpyrifos residues were
not generally bioavailable. In most cases,
no detectable residues were dislodged by
the carpet drags or the hard-toywipes, and,
therefore, were presumably not bioavailable
for humans contacting these surfaces. The
conservatively estimated total absorbed
dose for children ranged from 0.26 to
2.1 pg/kg bw/day, or 0.26-2.1% of the
acute NOEL for plasma cholinesterase
inhibition (Table 5). The comprehensive
multipathway exposure evaluation for resi-
dents following crack and crevice treat-
ments supports the safety of this use pat-
tern. High margins of exposure calculated
for children and adults indicate that neither
subpopulation would receive an exposure
of biological significance following a crack
and crevice application.
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